Guidelines for the Use of Cannabinoid Compounds in Chronic Pain

Simple item page
dc.contributor.authorClark, AJ
dc.contributor.authorLynch, ME
dc.contributor.authorWare, M
dc.contributor.authorBeaulieu, P
dc.contributor.authorMcGilveray, IJ
dc.contributor.authorGourlay, D
dc.date.accessioned2018-09-27T12:19:02Z
dc.date.available2018-09-27T12:19:02Z
dc.date.issued2005-01-01
dc.date.updated2018-09-27T12:19:02Z
dc.description.abstractOBJECTIVE: To provide clinicians with guidelines for the use of cannabinoid compounds in the treatment of chronic pain.METHODS: Publications indexed from 1990 to 2005 in the National Library of Medicine Index Medicus were searched through PubMed. A consensus concerning these guidelines was achieved by the authors through review and discussion.RESULTS: There are few clinical trials, case reports or case series concerning the use of cannabinoid compounds in the treatment of chronic pain. There are no randomized clinical trials examining the use of herbal cannabis in the treatment of chronic pain.CONCLUSIONS: A practical approach to the treatment of chronic pain with cannabinoid compounds is presented. Specific suggestions about the off-label dosing of nabilone (Cesamet, Valeant Canada limitée/Limited) and dronabinol (Marinol, Solvay Pharma Inc, Canada) in the treatment of chronic pain are provided.
dc.description.versionPeer Reviewed
dc.identifier.citationAJ Clark, ME Lynch, M Ware, P Beaulieu, IJ McGilveray, and D Gourlay, “Guidelines for the Use of Cannabinoid Compounds in Chronic Pain,” Pain Research and Management, vol. 10, no. Suppl A, pp. 44A-46A, 2005. doi:10.1155/2005/894781
dc.identifier.doihttps://doi.org/10.1155/2005/894781
dc.identifier.urihttp://hdl.handle.net/1880/108562
dc.identifier.urihttps://doi.org/10.11575/PRISM/45715
dc.language.rfc3066en
dc.rights.holderCopyright © 2005 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleGuidelines for the Use of Cannabinoid Compounds in Chronic Pain
dc.typeJournal Article

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PRM.2005.894781.pdf
Size:
244.38 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Open Access Publications

Powered by

Libraries & Cultural Resources

Start Something.

University of Calgary
2500 University Drive NW
Calgary Alberta T2N 1N4
CANADA

Copyright © 2023

The University of Calgary, located in the heart of Southern Alberta, both acknowledges and pays tribute to the traditional territories of the peoples of Treaty 7, which include the Blackfoot Confederacy (comprised of the Siksika, the Piikani, and the Kainai First Nations), the Tsuut’ina First Nation, and the Stoney Nakoda (including Chiniki, Bearspaw, and Goodstoney First Nations). The City of Calgary is also home to the Métis Nation of Alberta (Districts 5 and 6).

The University of Calgary is situated on land Northwest of where the Bow River meets the Elbow River, a site traditionally known as Moh’kins’tsis to the Blackfoot, Wîchîspa to the Stoney Nakoda, and Guts’ists’i to the Tsuut’ina. On this land and in this place we strive to learn together, walk together, and grow together “in a good way.”